Work

Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical and Experimental Rheumatology

DOI: 10.55563/clinexprheumatol/2t27x9

Authors: Hua Ye, Shengyun Liu, Yongjun Mei, Jieruo Gu, Min Yang, Li Zhang, Guoqin Wang, Zhimei He, Feiyan Wu, Yuyan Zheng, Michelle Xia, Baiyong Li, Zhanguo Li

Institutions: Peking University People's Hospital, First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Bengbu Medical College, Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University, Nanfang Hospital

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415294168

FWCI:

Cites:

Cited by:

Related to: